Reuters logo
Astrazeneca buys early-stage U.S. biotech firm
April 3, 2013 / 7:21 AM / 5 years ago

Astrazeneca buys early-stage U.S. biotech firm

LONDON, April 3 (Reuters) - Astrazeneca said on Wednesday that its MedImmune unit has bought AlphaCore Pharma, a US-based biotechnology company focused on heart treatments.

Financial details of the acquisition were not disclosed.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below